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Histone 3 lysine 4 trimethylation (H3K4me3) is asso-
ciated with promoters of active genes and found at
hot spots for DNA recombination. Here we have
shown that PAXIP1 (also known as PTIP), a protein
associated with MLL3 and MLL4 methyltransferase
and the DNA damage response, regulates RAG-
mediated cleavage and repair during V(D)J recombi-
nation in CD4+ CD8+ DP thymocytes. Loss of PAXIP1
in developing thymocytes diminished Ja H3K4me3
and germline transcription, suppressed double
strand break formation at 30 Ja segments, but re-
sulted in accumulation of unresolved T cell receptor
a-chain gene (Tcra) breaks. Moreover, PAXIP1 was
essential for release of mature single positive (SP)
ab T cells from the thymus through transcriptional
activation of sphingosine-1-phosphate receptor
S1pr1 as well as for natural killer T cell development.
Thus, in addition to maintaining genome integrity
during Tcra rearrangements, PAXIP1 controls dis-
tinct transcriptional programs during DP differentia-
tion necessary for Tcra locus accessibility, licensing
mature thymocytes for trafficking and natural killer
T cell development.
INTRODUCTION
DNA-mediated processes including transcription and DNA
repair are regulated by posttranslational modifications of theIhistone components of chromatin (Taverna et al., 2007). Post-
translational modifications are carried out by histone methyl-
transferases and demethylases, histone acetyltransferases,
protein kinases, and ubiquitin- and SUMO-protein ligases. Spe-
cific histone modifications are recognized by so called ‘‘reader-
effector’’ modules in nonhistone proteins. Such reader proteins
frequently carry enzymatic activity on the chromatin template,
which can render the DNA more accessible to the transcription
and/or DNA repair machineries (Taverna et al., 2007).
The recombination activating genes (Rag1 and Rag2) are
lymphoid-specific proteins that are essential for V(D)J recombi-
nation, a process that generates diversity in the antigen receptor
repertoire (Gellert, 2002; Schatz and Swanson, 2011). RAG1 and
RAG2 (herein referred to as RAG) bind and cleave DNA at spe-
cific recombination signal sequences (RSSs) that flank each V,
D, and J gene segment. Thereafter the liberated DNA ends are
recognized and repaired by the nonhomologous end joining
(NHEJ) pathway. The ability of RAG to initiate V(D)J recombina-
tion is dictated by the accessibility of RSSs within chromatin
(Krangel, 2007; Osipovich and Oltz, 2010).
The first clue about the mechanisms regulating RAG activity
was the discovery that germline transcripts of antigen receptor
gene segments correlate with recombinationally active open
chromatin configuration susceptible to double strand break
(DSB) cleavage (Yancopoulos and Alt, 1985). The link between
transcription, chromatin structure and recombination was
strengthened by studies documenting the effects of transcrip-
tional blockade on downstream histone modifications and
RAG-dependent DSBs (Abarrategui and Krangel, 2006). A
further link between germline transcription and increased acces-
sibility was the discovery that RAG is targeted to histone 3 lysine
4 trimethylation (H3K4me3) (Liu et al., 2007; Matthews et al.,
2007). The RAG2 protein contains a PHD finger at its C terminus,mmunity 37, 971–985, December 14, 2012 ª2012 Elsevier Inc. 971
Figure 1. PAXIP1 Regulates Thymocyte Development
(A) Flow cytometric analysis of WT and Paxip1/ thymocytes stained with antibodies against CD4 and CD8.
(B) Graphs showing numbers of total, DPs, CD4+, and CD8+ thymocytes from WT (black) and Paxip1/ (red) mice. Average number in each population is
indicated by the dashed line.
(C) TCRb, Qa2, and HSA expression in CD4+ and CD8+ cells from WT (black) and Paxip1/ thymocytes. Same number of total thymocytes from WT and
Paxip1/ were collected for flow cytometry.
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Role of Paxip1 in T Cell Developmentwhich interacts with H3K4me3. H3K4me3 is highly enriched in
the 50 end of all transcription units including chromatin encom-
passing recombinationally active genes in the immunoglobulin
and T cell receptor loci. A recent study reported that RAG2 binds
to virtually all genomic regions containing H3K4me3 (Ji et al.,972 Immunity 37, 971–985, December 14, 2012 ª2012 Elsevier Inc.2010). Moreover, RAG2 association with H3K4me3 is dependent
on the RAG2PHDdomain (Ji et al., 2010), and lymphocyte devel-
opment is partially impaired by PHD mutations that affect
RAG20s recognition of H3K4me3 (Matthews et al., 2007). Finally,
biochemical studies revealed that H3K4me3 stimulates the
Figure 2. Decreased Number of Peripheral T Cells in the Absence of PAXIP1
(A) Left panel, flow cytometric analysis of WT and Paxip1/ lymph node shows a decreased frequency of TCRb+, CD4+, and CD8+ SP cells in Paxip1/
thymocytes. Right panel, bar graph shows the average number of T cells in WT and Paxip1/ lymph node (n = 16 mice).
(B) Frequency of CD4+ and CD8+ T cells in spleen (left) and percentage of CD19+ and CD3+ lymphocytes in blood respectively was detected by flow cytometry.
Representative examples are shown. Bar graphs (bottom) show the average number of CD4+ andCD8+ SP T cells in spleen (n = 9mice) andCD19+ andCD3+ cells
in blood (n = 5 mice) from WT and Paxip1/ mice. Error bars represent SD.
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Role of Paxip1 in T Cell Developmentcatalytic function of RAG (Grundy et al., 2010; Shimazaki et al.,
2009). Altogether, these studies suggest a model in which
RAG2 association with H3K4me3 via its PHD-finger domain
enhances DNA binding and cleavage. In this way beyond the
recognition of the RSS in the DNA, the PHD chromatin reader
in RAG recombinase increases the efficiency of V(D)J
recombination.
Trimethylation of H3K4 is mediated by H3K4 methylases,
which include at least six members (Set1A, Set1B, MLL1,
MLL2, MLL3, and MLL4), each of which contains a conserved
SET domain carrying the methyltransferase activity. Each
H3K4 methylase exists in a large protein complex, which sharesIfour common subunits: ASH2L, RBBP5, WDR5, and DPY30.
Deletion of WDR5 results in a marked reduction of the recombi-
nation activity of RAG2 (Matthews et al., 2007), consistent with
a role for H3K4me3 in enhancing V(D)J recombination. In addi-
tion to shared subunit composition, methylase complexes
contain unique components, which may provide target speci-
ficity to the complex. For example, PAXIP1 (Pax interaction
with transcription-activation domain protein-1), is a subunit of
the MLL3 and MLL4 complex (Cho et al., 2007; Issaeva et al.,
2007; Patel et al., 2007) that regulates H3K4me3 and germline
transcription initiation at immunoglobulin g3 (IgG3) and IgG1
switch regions during class switch recombination (Daniel et al.,mmunity 37, 971–985, December 14, 2012 ª2012 Elsevier Inc. 973
Figure 3. PAXIP1 Regulates Tcra Recombination
(A) Loss of PAXIP1 decreases H3K4me3 at 30 Ja segments in DP T cells. Gene tracks represent position of H3K4me3 across a region spanning Ja segments inWT
(top) andPaxip1/ (bottom). The x axis represents the linear sequence of genomic DNA, and the y axis represents the total number ofmapped reads permillion of
mapped reads in 200 nucleotide windows. The genomic scale in kilobases (kb) is indicated above each track.
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Role of Paxip1 in T Cell Development2010; Schwab et al., 2011) (MLL3 is also known as KMT2C, and
MLL4 is also known as ALR, MLL2, or KMT2D)(Cho et al., 2012).
Transcription of switch regions is thought to render them in an
accessible configuration that allows DNA cleavage by the
enzyme activation induced deaminase (AID) (Stavnezer et al.,
2008). Nevertheless, loss of Paxip1 does not affect amounts of
H3K4me3 or transcription of Sm and Sε, indicating that the
PAXIP1-MLL3-MLL4 complex promotes accessibility of some
but not all switch loci (Daniel et al., 2010).
RAG and AID-dependent DNA breaks at antigen receptor
locus are marked by the phosphorylation of the histone variant
H2AX (g-H2AX) (Chen et al., 2000; Petersen et al., 2001). In addi-
tion to promoting germline transcription at the IgH locus, PAXIP1
exists in a separate complex that accumulates at sites of DNA
damage in a manner dependent on the g-H2AX DNA damage
response pathway (Gong et al., 2009). Beyond promoting AID
accessibility for IgG3 and IgG1 class switch recombination,
PAXIP1 appears to function subsequently in the repair of a subset
of AID dependent DSBs (Daniel et al., 2010).
Because H3K4me3 is thought to influence the accessibility of
chromatin at V(D)J gene segments, it is of interest to determine
the methylase activities that target the recombinase to specific
loci. Here we have analyzed thymic development in mice
deficient in PAXIP1. We have found that PAXIP1 controls RAG-
mediated DSB formation and repair during Tcra recombination.
Moreover, the development of natural killer T (NKT) cells, which
require recombination and expression of a very limited and
invariant TCRa chain, was ablated in the absence of PAXIP1.
Surprisingly, mature Paxip1/ thymocytes that successfully
completed V(D)J recombination failed to exit the thymus due to
impaired expression of the G protein-coupled sphingosine-1
phosphate receptor 1 (S1PR1). Thus, PAXIP1 regulates both re-
combinase accessibility and DNA repair in double positive (DP)
T cells as well as the exit of mature single positive (SP) T cells
from the thymus. We propose that PAXIP1 serves as a gate-
keeper that ensures that cells with faulty rearrangements are
not exported to the periphery.
RESULTS
PAXIP1 Regulates ab T Cell Development
To determine the physiologic consequence of Paxip1 loss during
T cell development, we crossed Paxip1f/f mice with mice ex-
pressing Cre recombinase driven by the Lck proximal promoter
(Hennet et al., 1995), which is active in immature thymocytes.
Expression of Paxip1 in mutant thymocytes was barely detect-(B) Ja usage in Paxip1/ DP thymocytes relative to WT normalized to 1 for each
(C) Expression of TCR Ca transcripts in WT and Paxip1/ DP T cells (mean ± S
(D) TRAV12 (Va8)-Ja coding joints in Paxip1/ DP thymocyte genomic DNA re
experiments).
(E) DSBs were detected in serial 3-fold dilutions of genomic DNA isolated fromWT
two independent experiments are shown.
(F) H3K4me3 ChIPseq profiles of the Tcra locus from Rag2/ 3 TCRb 3 Paxip
decreased tag counts in absence of PAXIP1.
(G) Germline transcript abundance in Rag2/ Paxip1/ compared with Rag2/
(H) Genomic instability analysis ofmetaphase spreads from thymocytes stimulated
Ca locus at chromosome 14 are represented in black. General instability outside t
of normal and broken chromosome 14 at the TCRad locus are shown. Arrow poin
in blue.
Iable by quantitative RT-PCR (qRT-PCR), confirming the effi-
ciency of deletion (see Figure S1 available online). In Paxip1f/f x
Lck Cre (referred to asPaxip1/) mice, total thymocyte recovery
was reduced to 50% of Paxip1f/f (referred to as wild-type [WT])
mice (Figures 1A and 1B). Consistent with this, staining for
CD4 and CD8 coreceptors in 6- to 10-week-old mice revealed
a 25% decrease in the percentage and 50% decrease in the
number of double positive (DP) thymocytes (Figures 1A and
1B), whereas the percentage of double negative (DN) thymo-
cytes was similar (Figure S2A). The DN-DP thymocyte transition
is associated with an approximately 100-fold expansion in
thymus cellularity. We considered the possibility that reduced
number of DP T cells might reflect inefficient proliferation. To
test this, we examined the expression of CD25 that gets diluted
during the DN-DP T cell transition (Crompton et al., 1994) (Fig-
ure S2B). Consistent with this, we observed a 3-fold increase
in the percentage of Paxip1/ DP T cells expressing CD25,
indicative of decreased proliferation (Figure S2B).
Unlike the reduction in DP thymoctyes, we observed an unex-
pected increase in the number of CD4+ andCD8+SPT cells in the
Paxip1/ thymus (Figures 1A and 1B). SP thymocytes that accu-
mulate in the absence of Paxip1 were mature T cells, evidenced
by a greater frequency of Paxip1/ SP T cells that express high
amounts of TCRb, CD69, and thematurationmarker Qa2 and low
amounts of heat stable antigen (HSA) in both CD4+ and CD8+
populations (Figures 1A and 1C; Figure S2C;). Associated with
the accumulation of SP T cells in the thymus, there was amarked
depletion in the number of mature Paxip1 deficient T cells in the
periphery (Figure 2). Whereas 78% of cells in WT lymph nodes
were T cells, defined as TCRb+, only 42% of Paxip1/ cells
expressed TCRb; moreover, there was 80% reduction in the
number of CD4+ and CD8+ T cells in this compartment (n = 16
mice analyzed) (Figure 2A). Finally, Paxip1 deletion resulted in
a 75% reduction in the number of splenic T cells (n = 9) as well
as a reduction of T cells in blood (Figure 2B). The paucity of
peripheral T cells (Figure 2) concomitant with the accumulation
of mature T cells in thymus (Figure 1) suggested the possibility
that PAXIP1 was required for T cell migration from the thymus
to the periphery (see below).
PAXIP1 Regulates Tcra Gene Recombination
The Tcra locus becomes accessible at the DP stage which
correlates with Ja chromatin marked by H3K4me3 (Krangel,
2007). We used chromatin immunoprecipitation (ChIP) coupled
with Illumina sequencing to examine genome-wide H3K4me3
profiles of DP T cells (CD4+CD8+TCRlo/med), CD4+ SP T cellsJa (mean ± SEM of two independent experiments).
EM of two independent experiments).
lative to WT normalized to 1 for each Ja (mean ± SEM of two independent
and Paxip1/DP thymocytes and were detected by Southern blot. Results of
1f/f x Lck Cre+ and Rag2/ 3 TCRb x Paxip1f/f 3 Lck Cre DP T cells show
 DPs as measured by real-time PCR.
with anti-CD28 and anti-TCRb for 2 days. Aberrations associatedwith the TCR
he TCR Ca locus is represented in gray. Schematic and representative images
ts to TCRad locus (green), telomere is shown in red, and DAPI counterstain is
mmunity 37, 971–985, December 14, 2012 ª2012 Elsevier Inc. 975
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Role of Paxip1 in T Cell Development(CD4+CD8TCRhi) and CD8+ SP T cells (CD4CD8+TCRhi) pop-
ulations from sorted WT and Paxip1/ thymocytes. Primary re-
arrangements utilize Ja segments at the 50 end of the 65 kb Ja
array and secondary Va-Ja rearrangements make use of addi-
tional Ja segments located 30 of the primary Va-Ja (Krangel,
2007). In WT DP T cells, we found that the sequence tag distribu-
tion of H3K4me3 was evenly spread along Ja locus as previously
reported (Ji et al., 2010) (Figure 3A). In contrast, Paxip1/ DP
T cells displayed a skewed H3K4me3 profile with the highest
H3K4me3 signals at the 50 Ja segments and a gradual decay
toward the 30 end of the Ja array (Figure 3A). For example, in
WT DP thymocytes, 41% of the total tag counts within the 65
kb Ja array were 30 of Ja30, whereas tag counts at the 30 end
of the locus were reduced to 13% in Paxip1/ DPs (Figure 3A).
Consistent with the results in DP T cells, the distribution of
H3K4me3 in Paxip1/ CD4+ SP and Paxip1/ CD8+ SP
T cells also showed skewing toward 50 relative to 30 segments
(Figure S3A). Thus, loss of Paxip1 results in decreased
H3K4me3 at 30 Ja segments in both DP and SP T cells.
To determine whether decreased H3K4me3 at 30 Ja segments
correlated with impairment in Va to Ja rearrangements, we
examined the Ja repertoire in WT and Paxip1/ thymocytes.
TCRblo/med DP cells were sorted and TCR transcripts were
reverse transcribed and PCR amplified with a TRAV12 (Va8)
family primer and a Ca primer, as previously described (Guo
et al., 2002; Hawwari et al., 2005). Ja usage was then assessed
by Southern blotting with a series of Ja-specific oligonucleotide
probes. This analysis of cDNA revealed greater utilization of 50
segments and less usage of 30 Ja segments in Paxip1/ thymo-
cytes relative to WT (Figure 3B). Moreover, DP thymocytes from
Paxip1/ mice showed decreased TCR Ca messenger RNA as
measured by quantitative RT-PCR (Figure 3C).
To determine whether skewed Ja usage is due to biased Va
to Ja recombination, we utilized DNA from sorted TCRblo/med
DP thymocytes to amplify genomic fragments generated by
TRAV12 (Va8) to Ja rearrangements by real-time PCR. Recombi-
nation from TRAV12 to 50 Ja segments were detected at a similar
amount in Paxip1/ and WT thymocytes (Figure 3D). However,
DNA rearrangements to more distal 30Ja segments (e.g., Ja37-
Ja2) were reduced in Paxip1 mutant cells relative to WT thymo-
cytes (Figure 3D). Thus, decreased 30 Ja usage and transcription
(Figures 3B and 3C) correlates with defective Va to Ja rearrange-
ments (Figure 3D) in Paxip1/ thymocytes.
Altered 30 Ja usage and recombination in Paxip1 deficient
thymocytes could result from increased programmed cell death
of DP thymocytes as seen in Rorc-deficient mice (Guo et al.,
2002), deregulation of Rag expression in DP thymocytes (Yan-
noutsos et al., 2001), or decreased cleavage of Tcra segments.
We found that the viability of Paxip1/ thymocytes (62%) was
comparable to WT (67%) after overnight culture (Figure S3B).
Moreover, RAG expression was not decreased in the absence
of Paxip1 (Figure S3C), indicating that lack of 30 Ja usage was
not due to shortened DP T cells life span or deregulated recom-
binase expression.
Although RAG expression was intact in Paxip1/ thymocytes
(Figure S3C), impaired RAG-mediated cleavage of 30 Ja seg-
ments could account for altered Ja usage and recombination.
To examine the efficiency of DNA double strand break formation,
we performed ligation-mediated PCR to amplify Ja signal ends976 Immunity 37, 971–985, December 14, 2012 ª2012 Elsevier Inc.as described (McMurry et al., 1997). We found that DSBs formed
efficiently in Paxip1/ thymocytes at 50 Ja segments (e.g., Ja61,
Ja58, and Ja49) (Figure 3E). However, there was a dramatic
decrease in DSB formation at 30 end of the Ja array (e.g., at
Ja27, Ja13, and Ja6) (Figure 3E). Thus, deficiency in PAXIP1-
dependent H3K4me3 at 30 Ja genes correlates with impaired
cleavage of those segments.
Primary Tcra rearrangements are dependent on transcription
mediated by T early a (TEA) and Ja49 promoters at the 50 end
of the array, which limits recombination to the 50 Ja61-Ja52
gene segments. After initial Va-Ja rearrangements, Va pro-
moters drive subsequent rounds of secondary rearrangements
to Ja segments that are more 30 (Hawwari and Krangel, 2007).
During primary and secondary rearrangements, the accessibility
to limited sets of Ja segments correlates with activating histone
marks such as H3K4 trimethylation (Abarrategui and Krangel,
2006).
One possible explanation for the alteration in TCRa repertoire
is that Paxip1 deficiency reduces H3K4me3 and germline tran-
scription throughout Ja rearrangements. If this were the case,
the most profound recombination deficit might appear at the
30 end of the locus, as observed, because 30 recombination
is dependent on prior 50 rearrangements (Krangel, 2007), and
each step would be less efficient in the absence of Paxip1. To
examine the effects of Paxip1 on H3K4me3 and transcription
at the 50end of the locus without the confounding effects
of ongoing rearrangements, we crossed Paxip1/ mice with
Rag2/ mice expressing a rearranged Tcrb transgene. In the
absence of Rag2, all recombination is eliminated. However, the
presence of the Tcrb transgene allowed the Tcra locus to be
transcriptionally active and in a configuration whereby only 50
Ja segments were accessible. Comparison of H3K4me3 in the
50 end of the Ja array in Rag2/3 TCRbb 3 Paxip1
f/f x Lck
Cre+ (Rag2/ Paxip1/) versusRag2/3 TCRbb3Paxip1
f/f3
Lck Cre - (Rag2/) DP T cells revealed that PAXIP1 deficiency
resulted in a 44% reduction in the number of sequence tags
focused at Ja61-Ja52 (Figure 3F). In addition, there was a reduc-
tion in germline transcripts at all accessible Ja elements and an
overall reduction in Tcra transcripts in Rag2/ Paxip1/ DP
T cells relative to Rag2/ (Figure 3G). These data suggest that
PAXIP1 contributes to the accessibility of the Tcra locus by
promoting H3K4me3 and germline transcription throughout the
Ja cluster.
In addition to its role in transcription, PAXIP1 is recruited to
sites of DNA damage where it promotes DSB repair by homolo-
gous recombination (Wang et al., 2010b). We observed that 50 Ja
segments are cleaved in the absence of Paxip1 (Figure 3E), and
therefore we could assesswhether DSBs are efficiently resolved.
To ascertain whether Tcra and Tcrd locus integrity is compro-
mised, we assayed for TCRa and d associated chromosomal
aberrations in metaphases spreads prepared from thymocytes.
We performed FISH analysis with a Tcra and Tcrd locus probe
that hybridizes to the middle of chromosome 14 together with
a telomeric probe, which marks the ends of all chromosomes.
Whereas TCRa and d associated chromosomal aberrations
were undetectable inWT thymocytes, 2.2% of Paxip1/ thymo-
cytes showed a broken chromosome 14 evident by the Tcra
probe hybridizing to the end of a shortened chromosome 14 (Fig-
ure 3H). This amount of TCRa and TCRd associated breaks is
Figure 4. PAXIP1 Is Essential for NK T Cell Development and Differentiation
(A) Top panel shows flow cytometry of WT and Paxip1/ thymocytes stained with PBS-57 loaded CD1d-tetramer (CD1 dTet+) and anti-CD24 (HSA). Bottom
panel shows CD44 and NK1.1 expression on gated HSAloCD1 dTet+ thymocytes.
(B) Splenocytes stained with CD1 dTet+ and anti-TCRb.
(C) Quantitation of NK T cell numbers in thymus (n = 4 mice analyzed for each genotype).
(D) qRT-PCR analysis of Va14-Ja18 rearrangements in WT and Paxip1/ thymocytes.
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Role of Paxip1 in T Cell Developmentsimilar to that observed in mice lacking the NHEJ factor 53BP1
(Difilippantonio et al., 2008). In addition to TCRa and d associated
aberrations, there was a 4-fold increase in spontaneous DNAIdamage in Paxip1/ thymoctyes (Figure 3H), consistent with a
role for PAXIP1 in repairing replication-associated DSBs (Wang
et al., 2010b) and with the observed decreased cellularity ofmmunity 37, 971–985, December 14, 2012 ª2012 Elsevier Inc. 977
Figure 5. PAXIP1 Dependent H3K4me3 at Promoters during Thymocyte Development
(A) Differences in the distribution of H3K4me3 at promoters in DP and SP T cells. The fold change in H3K4me3 normalized tags per million reads (TPM) at the
promoter of each gene in NCBI Build 37 RefSeq is indicated by color (left). The subset of geneswithmore than 3-fold change in H3K4me3 TPM ismagnified (right),
and representative genes for six identified categories are enumerated next to the color side bar (right).
Immunity
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Role of Paxip1 in T Cell DevelopmentPaxip1/ thymocytes (Figure 1B; Figure S2B).We conclude that
Ja rearrangements are less efficient in the absence of PAXIP1
because of impaired accessibility, cleavage, and DNA repair.
PAXIP1 Regulates NKT Lineage Development
Like conventional ab T cell lineages, NK T cells arise from DP
precursors in the thymus through secondary Tcra rearrange-
ment, TCR-mediated signaling, and selection (Godfrey and Ber-
zins, 2007). NK T cells that express an invariant Va14-Ja18 T cell
receptor recognize lipid antigen presented by the molecule
CD1d. Whereas Paxip1 deficiency resulted in a 50% decrease
in the total number of thymocytes, there was 90%–95%
decrease in the number of NK T cells stained by specific CD1d
tetramers in the mutant thymus and spleen (n = 4 mice analyzed)
(Figures 4A–4C). To determine the stage of NK T cell develop-
ment affected by the absence of Paxip1, we analyzed CD1d
tetramer-positive thymocytes for their expression of HSA,
CD44, and NK1.1. The few NKT cells in the Paxip1/ thymus
accumulated in the early immature populations (CD1dtetramer+
HSAloCD44loNK1.1) (Figure 4A), suggesting that the block in
NKT cell development is at early stages of positive selection.
To directly examine Va14-Ja18 rearrangements, we per-
formed quantitative RT-PCR with Va and Ja specific primers
(Gapin et al., 2001). Consistent with the fact that Ja18 is localized
at the 30 end of the Ja cluster, which is underutilized in the
absence of PAXIP1 (Figures 3A–3E), we found that Va14-Ja18
recombination was reduced 14 times in Paxip1/ thymocytes
(Figure 4D). Failure to generate the invariant Va14-Ja18 T cell
receptor provides an explanation for why NKT cell development
is arrested at early stages in the absence of PAXIP1.
PAXIP1 Contributes to Alterations in H3K4me3 during
the DP-SP T Cell Transition
Next, we attempted to identify geneswith deregulated H3K4me3
during the DP to SP T cell transition. To this end, we compared
the ChIP-Seq of H3K4me3 in DP, CD4+ SP, and CD8+ SP
T cell populations at gene promoters. In WT, the vast majority
(27,494; 98%) of H3K4me3 enriched genes were those that
were shared among DP and SP T cells (Figure 5A; Table S1; Fig-
ure S4A). Only 20 out of 27494 genes lost H3K4me3 during the
DP to SP T cell transition (Figure 5A; inset, row S1 and Table
S1) and 192 promoters gained H3K4me3 in both SP (CD4+ and
CD8+) T cell populations (Figure 5A, inset, row S6 and Table
S1). Nevertheless, a very small subset of H3K4me3 enriched
genes were found uniquely in CD8+ and CD4+ T cells (121 and
166 genes respectively, Figure 5A, inset, row S4 and S5 and
Table S1). For example, Runx3, which is upregulated during
CD8+ T cell differentiation (Wang et al., 2010a), showed
H3K4me3 in CD8+ but not in CD4+ SP T cells; Zbtb7b, which is
upregulated in CD4+ SP T cells (He et al., 2010), exhibited(B) PAXIP1 deficiency contributes to deregulation of H3K4me3 in less than 0.3%
negatively (blue) regulated by PAXIP1 is shown for CD4+ SP, CD8+ SP, and DP T
promoter is changed by at least 3-fold.
(C and D) Gain of H3K4me3 at promoters during WT DP to SP T cell developme
Scatterplot of CD4+ SP T cell and CD8+ SP T cell(C and D, respectively) show PA
H3K4me3 TPM between DPWT and CD4+ SP WT or CD8+ SP WT T cells (C and D
RefSeq. Genes with more than 3 times reduction or increase in SP Paxip1/
enrichment boundary is marked by dashed line. Promoter is defined as +/ 5Kb
IH3K4me3 binding in CD4+ but not in CD8+ SP T cells. Neverthe-
less, very few genes (<2% of total) acquire H3K4me3 during the
DP to SP T cell transition.
We next determined whether PAXIP1 contributed to H3K4 tri-
methylation by comparing the distribution of H3K4me3 in WT
and Paxip1/ sorted populations. In DP and SP T cells, the
vast majority of promoters (>99.95%) showed no dependence
of H3K4me3 on Paxip1 (Figure 5B). For example, when utilizing
a 3-fold threshold, only 10 genes out of 21,902 unique RefSeq
gene symbols showed altered H3K4me3 binding in Paxip1/
DP cells (Figure 5B) and only 93 genes showed at least a 2-
fold change (Figure S4B; Table S2). The majority of H3K4me3-
bound genes (3 genes in DPs, 36 genes in CD4+, and 32 genes
in CD8+ T cells) that were regulated by PAXIP1 showed an
increase in H3K4me3 in WT relative to Paxip1/ (Figure 5B;
Tables S2–S4; Figure S4B). Notable among those genes that ex-
hibited major deficits in H3K4me3 in Paxip1/ thymocytes was
Paxip1 itself (likely because the construct deletes the Paxip1
promoter, transcriptional start, and exon 1 [Patel et al., 2007])
and the sphingosine-1 phosphate receptor 1 S1pr1 (Figures
5A, 5C, and 5D).
To determine whether there is a correlation between the genes
that showed large deficits in H3K4me3 in the absence of Paxip1
(Figure 5B) and genes showing large alterations in H3K4me3 in
WT cells during the DP to SP T cell transition (Figure 5A), we
compared changes of H3K4me3 in SP Paxip1/ relative to SP
WT versus DP WT relative to SP WT T cells (Figures 5C and
5D). We found that 20 out of the 36 (56%) Paxip1-dependent
genes that were deregulated in CD4+ SP T cells (Figure 5B)
altered their amounts of H3K4me3 by more than three times
during the DP-SP T cell transition (Figure 5C). Similarly, 19 of
32 (60%) Paxip1-dependent genes in CD8+ SP T cells (Figure 5B)
exhibited a major increase in H3K4me3 during the DP-SP T cell
transition (Figure 5D). Overall, there was a greater effect from
Paxip1 deficiency on H3K4me3 for those genes that gained
H3K4me3 and thereby become transcriptionally activated during
DP-SP T cell differentiation, relative to those genes that did not
change H3K4me3 notably (Figures 5C and 5D, genes in quad-
rants I and II compared to III and IV, and P(chi-square test) <
1e-16 for both CD4+ and CD8+ SP T cells). Thus, despite the
fact that PAXIP1 was essential for H3K4 trimethylation in less
than 0.16% of promoters in SP T cells (36 out of 21,902) (Fig-
ure 5B), PAXIP1 contributed disproportionately to promoters in
which H3K4me3 increases during the DP-SP T cell transition
(27 out of 313 DP-SP promoters or 8.6%).
PAXIP1-Dependent H3K4me3 Correlates with PAXIP1
Binding to Promoters
To determine why only a subset of genes is a target for PAXIP1-
dependent H3K4me3, we performed genome-wide localizationof genes. The count of gene symbols unaffected (gray), and positively (red) or
cells. Gene is designated as PAXIP1-dependent when H3K4me3 TPM at the
nt correlates with deficit in H3K4me3 in the absence of PAXIP1 in SP T cells.
XIP1 -dependent H3K4me3 TMP fold enrichment (y axis) versus difference in
, respectively) (x axis). Each point depicts a gene’s promoter in NCBI Build 37
versus SP WT T cells are depicted in red or green, respectively. The 3-fold
from TSS.
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Figure 6. ChIP-seq Analysis of PAXIP1-Binding Sites
(A) PAXIP1-binding sites are enriched for Pax and Zbtb16 motifs. Enriched motif models at PAXIP1-bound sites were identified and computed relative to two
backgroundmodels as described in the methods. The motif of PAX paired-homeodomains was computed based on de novomotif analysis using ChIP-seq data.
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cytes. Because PAXIP1-binding showed some background
signals in Paxip1/ thymocytes, we considered only those
differentially enriched regions at gene promoters (n = 20,808) in
which PAXIP1-binding in WT exceeded Paxip1 deficient by
greater than 3-fold with false discovery rates less than 0.01
(see Experimental Procedures). To more rigorously assess the
PAXIP1-bound DNA sequences, we examined them for the
enrichment of consensusmotifs identified from publicly available
ChIP-Seq databases (see Experimental Procedures). We identi-
fied 25 motifs with more than 2-fold enrichment and log likeli-
hood ratio greater than 3 (Table S5; see Supplemental Experi-
mental Procedures). Using this method, we identified the
ZBTB16 and PAX family motifs as among the highest scoring
DNA sequences (Figure 6A; Table S5). Overall, 77% of the
PAXIP1-binding sites scored positive for at least one ZBTB16
consensus motif and more than 56% were positive for at least
one consensus paired domain or homeobox motif. It is known
that PAXIP1 and PAX1 physically associate and colocalize in
active chromatin (Lechner et al., 2000), and ZBTB16 has also
been reported to interact with PAXIP1 (Rual et al., 2005). These
observations support the specificity of our PAXIP1 binding
sequences.
The list of identified PAXIP1 bindings was then used for gene
ontology (GO) enrichment analysis, which enabled the identifica-
tion of biological processes that are affected by PAXIP1. Inter-
estingly, the top 11 enriched processes associated with the
strongest PAXIP1 targets were those involved in T cell/lympho-
cyte differentiation, activation and V(D)J recombination (Fig-
ure 6B; Table S6), suggestive of T cell-specific roles for PAXIP1
in thymocytes.
PAXIP1 preferentially bound to promoters and overlapped
with the closest nucleosome-free region to the transcription start
site, as determined by the normalized distribution of PAXIP1 and
H3K4me3 around transcription start sites (TSSs) (from +/2 kb
relative to TSS) (Figure 6C). On average, 91% of promoters
occupied by H3K4me3 had PAXIP1 binding, and conversely,
90% of PAXIP1-occupied promoters were also bound by
H3K4me3. Given the strong positive effect of PAXIP1 on differ-
ential H3K4me3 and expression of several genes that were upre-
gulated during the DP-SP T cell transition (Figure 5), we asked
whether we could discern the global effect of Paxip1 on cognate
sites of H3K4me3. By comparing the genome-wide localization
of PAXIP1 to H3K4me3, we found that increased PAXIP1 binding
intensity correlated with the extent of H3K4 trimethylation
(Figures S5A and S5B). Specifically, those genes in SP lineages
that showed the greatest deficits in H3K4me3 in the absence of
PAXIP1 were associated with significant PAXIP1binding in WT
T cells (Figures S5A and S5B).Motif models for PAX 2,4,6,8 and ZBTB16 were obtained from TRANSFAC (Matys
models have log likelihood ratio greater than 3 relative to the background model
(B) PAXIP1-binding sites are strongly associated with processes linked to T cell
T cell differentiation and activation. GREAT (McLean et al., 2010) was used for
binomial enrichment are shown.
(C) PAXIP1 is enriched at sites occupied by H3K4me3. The normalized tags per m
centered on the transcription starting sites (TSS) of NCBI Build 37 RefSeq genes
(D) Correlation between alteration in H3K4me3 and direct PAXIP1-binding. For ea
than 2-fold differential H3K4me3 (TSS +/ 5kb) was computed relative to a contr
promoters with the highest increase in H3K4me3 not exceeding 2-fold.
ITo further determine the frequency of PAXIP1-dependent
genes that exhibited direct PAXIP1 binding, we identified the
number of PAXIP1-occupied promoters that had at least 2-fold
increase in PAXIP1 dependent H3K4 trimethylation (as deter-
mined in Figure S4B). We compared this to control groups con-
sisting of the same number of genes taken from the next most
relevant PAXIP1-dependent promoters with the highest increase
in H3K4me3 not exceeding 2-fold. We observed 83%, 63%, and
25% increase in direct PAXIP1 association with the most signif-
icant PAXIP1-dependent promoters in CD8+ SP, CD4+ SP, and
DP T cell populations respectively relative to the controls (Fig-
ure 6D). Therefore, PAXIP1-dependent increases in H3K4me3
frequently result from direct binding of the PAXIP1 associated
methyltransferase complex near the promoter.
PAXIP1 Affects Thymocyte Egress by Regulating S1PR1
Expression
Because CD4+ and CD8+ SP T cells accumulate in PAXIP1-
deficient thymocytes (Figure 1), we hypothesized that genes
involved in cell migration might be deregulated in both popula-
tions. We therefore compared the distribution of H3K4me3 in
sorted CD4+ SP and CD8+ SP T cells from WT and Paxip1/
thymocytes. Relative to Paxip1/ CD4+ T cells, 36 genes from
WT CD4+ T cells had increased expression of H3K4me3 near
their promoters (Figure 5B; Figure 7A). Thirty-two genes in WT
CD8+ T cells also had increased H3K4me3 deposition relative
to Paxip1/ CD8+ thymocytes (Figure 5B; Figure 7A). Among
these genes with deregulated H3K4me3 at their promoters,
only nine exhibited an H3K4me3 deficit in both Paxip1/
CD4+ and CD8+ T lineages, which accumulate in the mutant
thymus (Figure 7A).
Examination of the list of common (CD4+ and CD8+ T cell)
downregulated genes in Paxip1/ SP T cells revealed that
the most important alteration, after Paxip1 itself, was in the
sphingosine-1-phosphate receptor S1pr1 (Figure 7B; Table
S7), which is essential for both ab and gd thymocyte and periph-
eral T cell emigration (Allende et al., 2004; Matloubian et al.,
2004; Odumade et al., 2010). We observed abundant signal for
H3K4me3 near S1pr1 for both CD4+ and CD8+ T cell lineages,
whereas H3K4me3 was barely detectable in the absence of
Paxip1 (Figure S6A). Another factor implicated in T cell homeo-
stasis was IL6st (Figure 7B), which encodes the IL-6 receptor
subunit, gp130. Surface staining for gp130 revealed that
Paxip1/ thymocytes were severely impaired in gp130 expres-
sion (Figure S6B).
In addition to S1PR1, the only other factors that have
been implicated in thymocyte emigration are FOXO1 and
KLF2 DNA binding proteins (Freitas and Rocha, 2009). Expres-
sion of all three factors (Figure 7C) and H3K4me3 associationet al., 2003) and PAZAR (Portales-Casamar et al., 2007), respectively. All motif
s.
development. Top shows that terms in biological process GO are enriched for
analysis of functional gene annotations. Only terms with greater than 2-fold
illion reads of PAXIP1 and H3K4me3 in a 50 bp window across a 4 kb region
is plotted.
ch lineage, the percent increase in PAXIP1 occupancy of promoters with more
ol set of the same size consisting of the next most relevant PAXIP1-dependent
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Figure 7. PAXIP1 Is Required for S1pr1 Expression
(A and B) A very few genes exhibit H3K4me3 deficit in both Paxip1/ CD4+ SP and Paxip1/ CD8+ SP T cell lineages. The Venn diagram shows the overlap of
genes with more than three times reduction in H3K4me3 TPM in both Paxip1/ CD4+ and CD8+ SP T cells. The numbers represent the total number of unique
gene symbol in each area.
(B) List of genes with more than three times reduction in H3K4me3 TPM in both Paxip1/ CD4+ and CD8+ SP T cells. The second and third columns show
H3K4me3 reduction in Paxip1/ CD4+ and CD8+ SP T cells with respect to WT CD4+ SP and CD8+ SP T cells, respectively.
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SP T cell transition; moreover, these gene products appeared to
function in the same pathway, because FOXO1 is critical for
KLF2 expression, which in turn drives S1PR1 expression (Freitas
and Rocha, 2009; Kerdiles et al., 2009). To determine whether
PAXIP1 promotes the expression of transcription factors critical
for thymocyte emigration, we directly assayed Foxo1, Klf2, and
S1pr1 expression in DP and SP cells by qRT-PCR. As predicted,
all three genes were upregulated during the DP-SP transition in
WT cells. Similarly, Foxo1 and Klf2 were also upregulated in
PAXIP1-deficient cells; however, S1PR1 RNA and protein failed
to be induced in Paxip1/ SP thymocytes (Figures 7C and 7D).
We conclude that among the factors known to drive thymo-
cyte egress and the size of the peripheral pool, S1PR1 appears
to be uniquely regulated by PAXIP1. Moreover, PAXIP1 bound
directly to the S1PR1 promoter (Figure S5C). S1PR1 deficiency
is characterized by a greater number of SP cells expressing b7
integrin and intermediate amount of CD69 in SP thymocytes
(Matloubian et al., 2004), and Paxip1/ SP thymocytes mirrored
this phenotype (Figure 7E). Additionally, we found a profound
accumulation of HSAlo mature gd T cells in the thymus that
also require PAXIP1 for thymic export (Odumade et al., 2010)
(Figure S2D). Together, these data demonstrate that among
several genes upregulated in mature SP thymocytes, PAXIP1 is
essential for induction of S1pr1 during the DP to SP T cell
transition.
In addition to S1pr1 and Paxip1, there are 7 genes in which
H3K4me3 is misregulated by more than 3-fold and 74 genes
decreased by at least 50% in Paxip1/ mature SP thymocytes
(Figures 7A and 7B; Table S7). To determine whether failure to
upregulate S1pr1 contributes to the accumulation of mature
thymocytes, we crossed Paxip1-deficient mice with mice ex-
pressing high amounts of an S1PR1 transgene under control of
the human Cd2 promoter (Liu et al., 2009). In contrast to Paxip1
deficiency, SP thymocytes no longer accumulated in S1PR1Tg
LckCre Paxip1f/f (Paxip1/S1PR1Tg) mice (Figure 7F), and the
frequency of CD4+ and CD8+ SP T cells in Paxip1/S1PR1Tg
was even lower than in WT. Moreover, S1PR1 overexpression
normalized Paxip1/ SP maturation, evidenced by a decrease
in frequency of Paxip1/S1PR1Tg cells expressing CD69 and
b7-integrin and an increase in SP cells expressing HSA relative
to Paxip1/ thymocytes (Figure 7F; Figure 1C). We conclude
that among various deregulated genes in SP thymocytes, defec-
tive S1PR1 expression is a primary factor influencing the accu-
mulation of T cells in the Paxip1 deficient thymus.
DISCUSSION
Here we have shown that the MLL3 and 4 specific cofactor
PAXIP1 regulates H3K4me3 in a subset of genes during thymo-
cyte development. PAXIP1 controlled accessibility in DP thymo-
cytes by promoting H3K4me3, transcription, and cleavagewithin(C) Expression of Foxo1, Klf2, and S1pr1 in sorted DP, CD4+, and CD8+ WT (bla
(D) Surface S1PR1 expression on TCRbhiCD69lo mature thymocytes from WT (b
(E) b7-integrin and CD69 expression in CD4+ SP T cells was measured by flo
thymocytes (red line).
(F) S1PR1 overexpression decreases accumulation of mature CD4+ and CD8+
maturation markers CD69, HAS, and b7-integrin in SP T cells.
IJa chromatin. Based on these findings, it is likely that RAG2
binding to the Ja locus is also reduced in the absence of
Paxip1; this could be the result of defective transcription and
associated chromatin opening as well as from diminished inter-
action between the RAG2 PHD domain and H3K4me3. In any
case, the PAXIP1-associated activity cannot be the only methyl-
transferase that targets RAG to the Tcra locus because the
reduction in H3K4me3 and transcription was only two times
lower in Paxip1/ thymocytes relative to WT. A consequence
of this redundancy is that Ja rearrangements are not eliminated
in the absence of PAXIP1 but instead are focused to the 50 end of
the Ja locus. Nevertheless, NK T cell development is blocked
due to failure to recombine to the Ja18 segment, which lies at
the 30 end of the Tcra locus.
While the 50 end of the Ja locus is efficiently broken, it is
inefficiently repaired, evidenced by the accumulation of TCRa
and TCRd associated chromosomal aberrations in Paxip1/
thymocytes. RAG mediated breaks are repaired by the NHEJ
pathway. Interestingly, PAXIP1 has been implicated in promot-
ing homologous recombination rather than NHEJ (Wang et al.,
2010b). Our ChIP analysis of genomic regions bound by PAXIP1
revealed that PAXIP1 associates near promoters (within 2 kb of
TSSs) of known NHEJ factors including XRCC4, DNA-PKcs,
and XRCC6 (Ku80). This suggests the possibility that PAXIP1’s
role in Tcra recombination might be linked to transcriptional
regulation of NHEJ factors. However, we have found no differ-
ence in the expression of NHEJ factors in WT and Paxip1 /
thymocytes as measured by qRT-PCR (data not shown).
Because PAXIP1 is recruited to DSBs in a MLL4-independent
but g-H2AX-dependent manner (Gong et al., 2009), it therefore
seems more likely that PAXIP1’s role in repair of RAG mediated
DSBs is directly mediated by recruitment to DSBs rather than
transcription of NHEJ proteins.
PAXIP1 regulates H3K4me3 in a small fraction of promoters in
developing T cells. Among the genes that are positively regu-
lated by PAXIP1 in CD4+ or CD8+ SP T cells, approximately
50% are those that changed H3K4me3 notably during the DP-
SP T cell transition. Moreover, many of the genes that showed
PAXIP1 dependence for H3K4me3 also exhibited PAXIP1
binding near their promoters. This indicates that PAXIP1 activity
is most important for a subset of T cell-specific genes whose
expression is induced during DP to SP T cell differentiation.
This includes S1pr1 but does not include other upregulated
genes such as Bcl2, Sell, and Il7r.
It has been reported that PAX2 and PAX5 recruit PAXIP1
and the H3K4 methyltransferase complex to PAX-dependent
genes (Patel et al., 2007; Schwab et al., 2011). If this mode of
recruitment is generalizable, it suggests that complexes con-
taining PAXIP1 and methyltransferases are targeted to DNA
through interactions with sequence-specific transcription fac-
tors. According to this hypothesis, transcription factors such
as FOXO1 or KLF2 might facilitate association of PAXIP1 withck) and Paxip1/ (red) thymoctyes measured by qRT-PCR.
lack) and Paxip1/ (red) mice.
w cytometry using the same number of total WT (black line) and Paxip1/
SP T cells in Paxip1 deficient thymocytes (top) and normalizes expression of
mmunity 37, 971–985, December 14, 2012 ª2012 Elsevier Inc. 983
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through ensuing H3K4me3. Other genes such as Bcl2, Sell,
and Il7r would be induced in a PAXIP1-independent manner
because transcription factors that activate these promoters
would not interact with PAXIP1.
Is there a connection between PAXIP1 functions in Tcra
rearrangement and thymoctye export? One possibility is that
PAXIP1 serves as a gatekeeper that ensures that developing
thymocytes with faulty rearrangements are not exported to
the periphery. Previously we have shown that in addition to
its role in DNA double strand break repair, the ATM kinase
prevents the transmission of DNA breaks to daughter cells
(Calle´n et al., 2007). Impairment of both these repair and check-
point functions may account for the high amount of antigen
receptor associated breaks in mature peripheral Atm/ lym-
phocytes, some of which are generated in earlier development
as a result of failed V(D)J recombination (Calle´n et al., 2007).
By promoting phosphorylation of H2AX, ATM is also required
for the recruitment of PAXIP1 to DSB sites (Gong et al., 2009).
PAXIP1 accumulation at DNA damage sites occurs indepen-
dently of the MLL3 and MLL4 methyltransferase complex
(Gong et al., 2009). Nevertheless, PAXIP1 association with sites
of DNA damage during Tcra rearrangements might effectively
deplete MLL3 and 4 of its transcription targeting cofactor
PAXIP1. In this case, there would be less efficient induction of
PAXIP1-dependent genes such as S1PR1 during the DNA
damage response, which in turn would reduce thymic export.
These two specialized roles of PAXIP1 in DNA repair and tran-
scription might therefore have evolved as part of a checkpoint
that prevents the propagation of potentially oncogenic DNA
damage out of the thymus.
EXPERIMENTAL PROCEDURES
Mice
Paxip1 f/f (Kim et al., 2007), TCRb transgenic (Shinkai et al., 1993), and Lck Cre
transgenic (Hennet et al., 1995) and S1PR1 transgenic (Liu et al., 2009) mice
were generated as previously described. Rag2/ mice were obtained from
Taconic Laboratories. All experiments were performed in compliance with
NIH Intramural Animal Care and Use program.
TCRa Repertoire and Recombination
Analysis of Ja usage in sorted TCRblo/med DP thymocytes was performed by
Southern blot and probing of TRAV12 (Va8)-CaRT-PCR productswith Ja-spe-
cific probes as described (Guo et al., 2002; Hawwari et al., 2005). TCRa tran-
scripts were analyzed by quantitative real-time PCR using a QuantiFast SYBR
Green PCR kit (QIAGEN). TCRa coding joints were analyzed in genomic DNA
of sorted DP thymocytes by quantitative real-time PCR as above, with normal-
ization to B2m. Primer sequences are provided in Table S8. Ja DSBs were
quantified in genomic DNA of sorted DP thymocytes by ligation-mediated
PCR (McMurry et al., 1997) using primers and probes described (Seitan
et al., 2011). Metaphases were obtained from thymocytes stimulated with
anti-TCR (H57, 2 mg/ml; PharMingen) and anti-CD28 antibodies (5 mg/ml; Phar-
Mingen) and analyzed with BAC probes containing the TCRa locus (TCR
Ca-232F18) and telomere-repeat specific peptide nucleic acid (PNA) probes
(Applied Biosystems).
qRT-PCR Analysis of Gene Expression
Total RNA was extracted with TRIzol (Invitrogen) or RNeasy mini kit (QIAGEN)
and was reverse transcribed with Superscript III cDNA synth (Invitrogen). qRT-
PCR was performed using SYBR Green (Perkin Elmer) with the 7900HT Fast
Real-time PCR system (Applied Biosystems). Primers used are listed in
Supplemental Experimental Procedures.984 Immunity 37, 971–985, December 14, 2012 ª2012 Elsevier Inc.Flow Cytometry
Single cell suspensions from thymocytes, lymph nodes, and spleen were iso-
lated from 6- to 10-week-old mice. Antibodies used for flow cytometric anal-
ysis are listed in Supplemental Experimental Procedures.
Chromatin Immunoprecipitation
At least 10 million sorted DP (CD4+CD8+TCRlo/med), CD4+ SP (CD4+CD8
TCRhi), and CD8+ SP (CD4CD8+TCRhi) populations was used to make
cross-linked chromatin. Chromatin was processed for H3K4me3 or PAXIP1
ChIP-Seq with Illumina sequencing as described (Daniel et al., 2010).
Computational and Statistical Analyses
Detailed description is available in the Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, six tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2012.10.007.
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